This research investigates how nicotine exposure influences the development of schizophrenia-like symptoms in mice, using a model induced by phencyclidine.
The study emphasizes that the timing of nicotine exposure relative to symptom development may be crucial in understanding comorbidities between smoking and schizophrenia.